ARTELO BIOSCIENCES, INC. Operating Cash Flow
ARTELO BIOSCIENCES, INC. (ARTL) reported Operating Cash Flow of -$6.22 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-12
- ARTELO BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$5.03M.
- ARTELO BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.19M.
- ARTELO BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$2.91M.
- ARTELO BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.50M.
- ARTELO BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$8.01M.
- ARTELO BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$6.14M.
- ARTELO BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2020 was -$4.35M.
- ARTELO BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2019 was -$2.79M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 4 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$6.22M 10-Q · filed 2026-08-12 | -$9.13M derived: sum of 3 quarters · filed 2026-08-12 | -$12.63M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2026-03-31 | -$1.19M 10-Q · filed 2026-05-14 | -$4.10M derived: sum of 2 quarters · filed 2026-05-14 | -$7.60M derived: sum of 3 quarters · filed 2026-05-14 | -$8.11M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-12-31 | -$2.91M derived: 8-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$6.41M derived: sum of 2 quarters · filed 2026-03-17 | -$6.92M derived: sum of 3 quarters · filed 2026-08-12 | -$8.52M 8-K · filed 2026-03-17 | |||
| 2025-09-30 | -$3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$4.01M derived: sum of 2 quarters · filed 2026-08-12 | -$5.61M 10-Q · filed 2025-11-12 | -$8.18M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-06-30 | -$514.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$2.11M 10-Q · filed 2026-08-12 | -$4.68M derived: sum of 3 quarters · filed 2026-08-12 | -$5.46M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-03-31 | -$1.60M 10-Q · filed 2026-05-14 | -$4.16M derived: sum of 2 quarters · filed 2026-05-14 | -$4.94M derived: sum of 3 quarters · filed 2026-05-14 | -$7.00M derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | -$2.57M derived: 8-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$3.35M derived: sum of 2 quarters · filed 2026-03-17 | -$5.41M derived: sum of 3 quarters · filed 2026-03-17 | -$8.35M 8-K · filed 2026-03-17 | |||
| 2024-09-30 | -$778.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$2.84M derived: sum of 2 quarters · filed 2025-11-12 | -$5.78M 10-Q · filed 2025-11-12 | -$8.38M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | -$2.06M derived: 10-Q 6 month − 8-K 3 month · filed 2025-08-13 | -$5.00M 10-Q · filed 2025-08-13 | -$7.60M derived: sum of 3 quarters · filed 2025-08-13 | -$9.40M derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | -$2.94M 8-K · filed 2025-07-11 | -$5.54M derived: sum of 2 quarters · filed 2025-07-11 | -$7.34M derived: sum of 3 quarters · filed 2025-07-11 | -$8.96M derived: sum of 4 quarters · filed 2025-07-11 | |||
| 2023-12-31 | -$2.60M derived: 8-K 12 month − 10-Q 9 month · filed 2025-07-11 | -$4.40M derived: sum of 2 quarters · filed 2025-07-11 | -$6.02M derived: sum of 3 quarters · filed 2025-07-11 | -$8.21M 8-K · filed 2025-07-11 | |||
| 2023-09-30 | -$1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$3.42M derived: sum of 2 quarters · filed 2024-11-12 | -$5.61M 10-Q · filed 2024-11-12 | -$7.90M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | -$1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$3.81M 10-Q · filed 2024-08-13 | -$6.10M derived: sum of 3 quarters · filed 2024-08-13 | -$7.80M derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | -$2.19M 10-Q · filed 2024-05-13 | -$4.48M derived: sum of 2 quarters · filed 2024-05-13 | -$6.17M derived: sum of 3 quarters · filed 2024-05-13 | -$8.14M derived: sum of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | -$2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$3.99M derived: sum of 2 quarters · filed 2024-03-25 | -$5.96M derived: sum of 3 quarters · filed 2024-03-25 | -$8.01M 10-K · filed 2024-03-25 | |||
| 2022-09-30 | -$1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$3.66M derived: sum of 2 quarters · filed 2023-11-13 | -$5.71M 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | -$1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$4.02M 10-Q · filed 2023-08-10 | |||||
| 2022-03-31 | -$2.05M 10-Q · filed 2023-05-11 | ||||||
| 2021-12-31 | -$2.67M 10-K · filed 2023-03-31 | ||||||
| 2021-11-30 | -$1.93M 10-Q · filed 2022-01-12 | ||||||
| 2021-09-30 | -$1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$4.86M 10-Q · filed 2022-11-08 | |||||
| 2021-08-31 | -$1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$6.14M 10-K · filed 2023-03-31 | |||||
| 2021-06-30 | -$1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$3.34M 10-Q · filed 2022-08-09 | |||||
| 2021-05-31 | -$1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-12 | -$4.60M 10-Q · filed 2021-07-12 | |||||
| 2021-03-31 | -$1.74M 10-Q · filed 2022-05-12 | ||||||
| 2021-02-28 | -$1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-13 | -$2.82M 10-Q · filed 2021-04-13 | -$3.69M derived: sum of 3 quarters · filed 2022-03-21 | -$4.71M derived: sum of 4 quarters · filed 2022-03-21 | |||
| 2020-12-31 | -$1.87M 10-KT · filed 2022-03-21 | ||||||
| 2020-11-30 | -$1.32M 10-Q · filed 2022-01-12 | -$1.32M 10-Q · filed 2021-01-14 | -$2.19M derived: sum of 2 quarters · filed 2022-03-21 | -$3.21M derived: sum of 3 quarters · filed 2022-03-21 | -$4.62M derived: sum of 4 quarters · filed 2022-03-21 | ||
| 2020-08-31 | -$872.33K derived: 10-KT 12 month − 10-Q 9 month · filed 2022-03-21 | -$1.89M derived: sum of 2 quarters · filed 2022-03-21 | -$3.30M derived: sum of 3 quarters · filed 2022-03-21 | -$4.35M 10-KT · filed 2022-03-21 | -$4.35M 10-K · filed 2020-11-04 | ||
| 2020-05-31 | -$1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-12 | -$2.42M derived: sum of 2 quarters · filed 2021-07-12 | -$3.47M 10-Q · filed 2021-07-12 | -$4.54M derived: sum of 4 quarters · filed 2021-07-12 | |||
| 2020-02-29 | -$1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-13 | -$2.45M 10-Q · filed 2021-04-13 | -$3.52M derived: sum of 3 quarters · filed 2021-04-13 | -$4.10M derived: sum of 4 quarters · filed 2021-04-13 | |||
| 2019-11-30 | -$1.05M 10-Q · filed 2021-01-14 | -$2.11M derived: sum of 2 quarters · filed 2021-01-14 | -$2.70M derived: sum of 3 quarters · filed 2021-01-14 | -$3.44M derived: sum of 4 quarters · filed 2021-01-14 | |||
| 2019-08-31 | -$1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-04 | -$1.65M derived: sum of 2 quarters · filed 2020-11-04 | -$2.39M derived: sum of 3 quarters · filed 2020-11-04 | -$2.79M 10-K · filed 2020-11-04 | |||
| 2019-05-31 | -$589.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-07-13 | -$1.33M derived: sum of 2 quarters · filed 2020-07-13 | -$1.73M 10-Q · filed 2020-07-13 | -$2.25M derived: sum of 4 quarters · filed 2020-07-13 | |||
| 2019-02-28 | -$740.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-13 | -$1.14M 10-Q · filed 2020-04-13 | -$1.66M derived: sum of 3 quarters · filed 2020-04-13 | -$2.11M derived: sum of 4 quarters · filed 2020-04-13 | |||
| 2018-11-30 | -$401.15K 10-Q · filed 2020-01-14 | -$915.02K derived: sum of 2 quarters · filed 2020-01-14 | -$1.37M derived: sum of 3 quarters · filed 2020-01-14 | -$1.84M derived: sum of 4 quarters · filed 2020-01-14 | |||
| 2018-08-31 | -$513.87K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-18 | -$972.64K derived: sum of 2 quarters · filed 2019-12-18 | -$1.44M derived: sum of 3 quarters · filed 2019-12-18 | -$1.61M 10-K/A · filed 2019-12-18 | |||
| 2018-05-31 | -$458.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-15 | -$926.26K derived: sum of 2 quarters · filed 2019-07-15 | -$1.10M 10-Q · filed 2019-07-15 | -$1.25M derived: sum of 4 quarters · filed 2019-07-15 | |||
| 2018-02-28 | -$467.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | -$637.38K 10-Q · filed 2019-04-15 | -$795.34K derived: sum of 3 quarters · filed 2019-04-15 | ||||
| 2017-11-30 | -$169.89K 10-Q · filed 2019-01-14 | -$327.85K derived: sum of 2 quarters · filed 2019-01-14 | |||||
| 2017-08-31 | -$157.96K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29 | -$216.82K 10-K · filed 2018-11-29 | |||||
| 2017-05-31 | -$58.86K 10-Q · filed 2018-07-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |